CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Short Interest Down 63.6% in December

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOYGet Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling 2,538 shares, a decline of 63.6% from the November 30th total of 6,974 shares. Based on an average daily volume of 33,732 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are sold short. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 33,732 shares, the short-interest ratio is currently 0.1 days.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Citigroup cut CochLear to a “neutral” rating in a report on Thursday, September 18th. Canaccord Genuity Group upgraded shares of CochLear from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Two research analysts have rated the stock with a Strong Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Analysis on CHEOY

CochLear Stock Performance

Shares of CochLear stock opened at $88.01 on Friday. CochLear has a 52 week low of $74.76 and a 52 week high of $105.60. The stock’s 50-day simple moving average is $90.51 and its 200-day simple moving average is $94.86.

CochLear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Read More

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.